Basalt Health Secured $20 Million Series A Funding
The healthcare startup aims to streamline patient referrals across hospital systems by the end of 2026.
Updated on Sept. 24, 2026 in Healthcare
Live Poll
Do you trust automated systems to manage hospital patient admissions and clinical matching?
Basalt Health raised $20 million in Series A financing, bringing its total capital to $24.5 million. The startup plans to scale its automated referral platform across 111 enterprise markets by the end of 2026.
Why it matters
The platform addresses the significant burden of manual chart processing in post-acute care, where inefficiencies contribute to $17 billion in avoidable annual readmission expenses. By automating clinical suitability evaluations, the system aims to improve care transitions for the 14 million patients entering post-acute settings annually.
Basalt Health reduced median chart processing time at Lifepoint Health by 86%, cutting turnaround from 8.5 minutes to 1.2 minutes. The platform is scheduled for deployment across 62 ScionHealth hospitals by December 2026.
The players
Basalt Health
This startup provides an automated platform designed to manage and evaluate patient referral packets for post-acute care facilities.
New Enterprise Associates
This venture capital firm acted as the lead investor for the company's $20 million Series A financing round.
Lifepoint Health
This national healthcare system served as an early partner for testing the company's automated referral processing tools.
ScionHealth
This hospital network has committed to deploying the automated platform across its facilities by the end of 2026.
The details
Founded in 2024, the platform automatically ingests referrals from fax, web portals, and EHR interfaces to evaluate patients against facility criteria and bed availability. This technology replaces labor-intensive manual review processes for clinical dossiers.
Timeline
Basalt Health was founded in 2024.
The Series A financing round was announced on September 24, 2026.
Deployment across 62 ScionHealth hospitals will conclude by December 2026.
Expansion into 111 total enterprise markets will conclude by the end of 2026.
Market Landscape
The startup competes in a growing health-tech sector focused on reducing administrative friction in the $17 billion annual market for avoidable patient readmissions. By securing significant capital, Basalt Health is positioning itself to capture market share from traditional, manual-heavy referral processing methods.
Patients may experience faster placement and fewer transition delays as healthcare providers adopt this automated referral technology. These efficiencies aim to lower the administrative burden on hospital staff while reducing the likelihood of costly and preventable readmissions.
The takeaway
Automating the ingestion of patient data can dramatically improve the speed of hospital discharges and post-acute care coordination. Health systems are increasingly turning to software solutions to replace manual document handling and decrease the financial impact of preventable readmissions.
What happens next
The company is slated to complete its deployment across 62 ScionHealth hospitals by December 2026, followed by the broader completion of its expansion to 111 enterprise markets by the end of that year.
Further reading
Learn more about the latest innovations in Healthcare affecting hospital administration.
Source note: This article includes information reported by Hitconsultant.
Live Poll
Do you trust automated systems to manage hospital patient admissions and clinical matching?
